INTELLIGENT BIO SOLUTIONS INC. Selling, General and Administrative Expense
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Selling, General and Administrative Expense of $10.50 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $2.99M, a 9.80% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.46M, a 1.82% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $2.34M, a 29.18% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $2.72M.
- INTELLIGENT BIO SOLUTIONS INC. selling, general and administrative expense for fiscal 2026 was $10.50M, a 17.76% increase from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. selling, general and administrative expense for fiscal 2025 was $8.92M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $5.45M derived: sum of 2 quarters · filed 2026-08-19 | $7.79M derived: sum of 3 quarters · filed 2026-08-19 | $10.50M 10-K · filed 2026-08-19 | |
| 2026-03-31 | $2.46M 10-Q · filed 2026-05-13 | $4.80M derived: sum of 2 quarters · filed 2026-05-13 | $7.51M 10-Q · filed 2026-05-13 | $10.24M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-12-31 | $2.34M 10-Q · filed 2026-02-12 | $5.00M 10-Q · filed 2026-02-12 | $7.78M derived: sum of 3 quarters · filed 2026-08-19 | $10.19M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-09-30 | $2.72M derived: 10-K 12 month − 3 quarters · filed 2026-08-19 | $5.44M derived: sum of 2 quarters · filed 2026-08-19 | $7.85M derived: sum of 3 quarters · filed 2026-08-19 | $9.66M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-06-30 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $5.14M derived: sum of 2 quarters · filed 2026-08-19 | $6.95M derived: sum of 3 quarters · filed 2026-08-19 | $8.92M 10-K · filed 2026-08-19 | |
| 2025-03-31 | $2.41M 10-Q · filed 2026-05-13 | $4.22M derived: sum of 2 quarters · filed 2026-05-13 | $6.20M 10-Q · filed 2026-05-13 | ||
| 2024-12-31 | $1.81M 10-Q · filed 2026-02-12 | $3.76M 10-Q · filed 2026-02-12 | |||
| 2023-12-31 | $1.71M 10-Q · filed 2024-02-09 | $4.16M 10-Q · filed 2024-02-09 | |||
| 2022-12-31 | $2.25M 10-Q · filed 2024-02-09 | $3.70M 10-Q · filed 2024-02-09 | $123.80K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |